Skip to content

Acupuncture plus Ear Press Needle for Parkinson's Disease with Constipation and Depression: A Brain-Gut Axis-Based Study

Acupuncture plus Ear Press Needle for Parkinson's Disease with Constipation and Depression: A Brain-Gut Axis-Based Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125559
Enrollment
Unknown
Registered
2026-05-28
Start date
2026-05-28
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Sponsors

Shanghai Pudong Hospital, Fudan University Pudong Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the above-mentioned diagnostic criteria for both traditional Chinese and Western medicine; 2. Age range: 45 to 80 years old, gender not restricted; 3. SDS score: 52 points < score <= 72 points; 4. Patients receiving Western medicine for Parkinson's disease treatment must have a stable medication regimen (including the dosage of Western medicine) for 4 weeks before entering the trial stage; 5. Those who have taken laxatives in the past, are required to discontinue the current laxative for 2 weeks before entering the trial stage. Before the trial, constipation can be treated by physical methods; 6. Clear consciousness, able to take care of daily life independently or with only minor assistance, willing to cooperate with the research and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with constipation caused by organic diseases of the intestines or the whole body, as well as by drug factors; 2. Those with severe primary diseases such as heart, liver, kidney and endocrine system disorders, malignant tumors, mental disorders or cognitive impairments, and those with infectious diseases; 3. Those who do not receive acupuncture treatment; 4. Those who are currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Patient Assessment of Constipation Symptoms (PAC-SYM);

Secondary

MeasureTime frame
Self-Rating Depression Scale (SDS);The Quality of Life Scale for Constipation Patients;5-hydroxytryptamine;Motilin;

Countries

China

Contacts

Public ContactLiang Zeng

Shanghai Pudong Hospital, Fudan University Pudong Medical Center

liam66@126.com+86 21 6803 5983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026